Developer docs
API playgroundTry for free, no card

Search company profiles

Medigray

Full company profile

uuid02lrbup

Namestring
Medigray
Legal namestring
Inversiones Oridama S.A.
Websiteurl
medigray.com
Company typeenum
Private
Founded yearint
1988
Short descriptiontext

Medigray (Inversiones Oridama S.A.) is a Costa Rican family-owned pharmaceutical manufacturer founded in 1988 that develops, produces, and commercializes more than 60 pharmaceutical, OTC, cosmetic, medical-device, and disinfectant products, supplying CCSS public healthcare, domestic pharmacy networks, and export distributors in four additional countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersDesamparados, Costa Rica
HQ citystring
Desamparados
HQ countrystring
Costa Rica
HQ regionstring
Latin America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, OTC medications, dermatological products, cosmetics production, medical device disinfectants
Industry1 code
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Manufacturing
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Revenue generated from developing, producing, and commercializing pharmaceutical products including prescription medications, OTC products, and cosmetics through direct institutional sales (CCSS public sector) and retail pharmacy distribution.

medigray.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Medigray is a Costa Rican pharmaceutical manufacturer that develops, produces, and commercializes a portfolio of more than 60 differentiated medications and cosmetics across therapeutic categories including respiratory, pain, dermatology, gastrointestinal, antiparasitic, cardiometabolic, urological, vascular, and high-level disinfection. Products are sold through direct institutional sales to the CCSS public healthcare system, pharmacy retail networks in Costa Rica, and export distribution to four additional countries in Central America and the Caribbean.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Medigray is a Costa Rican pharmaceutical company (founded 1988) that develops, produces, and commercializes pharmaceutical products and cosmetics. The product portfolio spans multiple therapeutic categories: Respiratory (Salbutín, Aquanasal, Herbatos), Pain/Anti-inflammatory (Megalivia, Golparén, Rolomed, Lidocaína Spray), Dermatological (Trofodermax, Biopantenol, Terminafín, Secaride, Fusicobiotic, Sport Ice), Gastric/Intestinal (Liviosan, Frutadex, Diabedex, Buco Vac), Urological (Urofos, Vigor, Vascumed), Antiparasitic (Piofín, Iverpiofin, Delix), Cardiometabolic (Diabecontrol, Ydrat), Multivitamins (IV Infusion), and High-Level Disinfectants (Ortoftaldehído, Glutaraldehído, Reactive Strips). The company also offers OTC products (Spin Deodorant, Otocerum, Lubrisex, Durasex, Aftotex, Alergel). Medigray exports to multiple countries including Dominican Republic, Panama, Peru, and El Salvador.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Eurofarma Laboratórios
TypeDirect peer
Description

Brazilian pharmaceutical manufacturer with operations across Latin America. Comparable as a Latin American pharma manufacturer with a diversified therapeutic portfolio and regional expansion strategy.

TypeBroad incumbent
Description

Global pharmaceutical company with established Latin American operations. Operates broadly in the same therapeutic categories as Medigray but at much larger scale with deeper R&D and regulatory resources.

TypeDirect peer
Description

Colombian pharmaceutical manufacturer with international presence across the Americas. Comparable as a regional branded pharma manufacturer with multi-country distribution and similar therapeutic-category breadth.

TypeBroad incumbent
Description

Global pharmaceutical incumbent with established presence across Latin America. Overlaps in anti-infectives, cardiometabolic, and dermatology but at much larger scale and with proprietary IP.

5Laboratorios Asofarma
TypeDirect peer
Description

Mexican pharmaceutical company focused on specialty pharma across Latin America. Comparable as a regional branded pharmaceutical manufacturer with presence in Central American and Latin American markets.

TypeRegional player
Description

Peruvian pharmaceutical manufacturer with regional presence. Comparable because Medigray already exports to Peru and operates in similar therapeutic categories; serves as a regional reference for Andean market dynamics.

TypeDirect peer
Description

Mexican pharmaceutical and personal care company focused on branded OTC products across Latin America. Highly comparable business model of developing and commercializing branded pharmaceutical and OTC products for Latin American markets.

TypeBroad incumbent
Description

Global pharmaceutical and life sciences company with extensive Latin American presence. Overlaps in OTC, cardiometabolic, and dermatology but as part of a much broader global portfolio.

TypeBroad incumbent
Description

Global generic and specialty pharmaceutical company. Operates in the same branded-generic space as Medigray but at vastly greater scale with a global manufacturing footprint.

10Laboratorios Roemmers
TypeDirect peer
Description

Argentine pharmaceutical manufacturer with regional presence across Latin America. Comparable as a regional pharmaceutical manufacturer with diversified product portfolio and multi-country footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medigray

Pharmaceutical Manufacturingmedigray.com

Medigray (Inversiones Oridama S.A.) is a Costa Rican family-owned pharmaceutical manufacturer founded in 1988 that develops, produces, and commercializes more than 60 pharmaceutical, OTC, cosmetic, medical-device, and disinfectant products, supplying CCSS public healthcare, domestic pharmacy networks, and export distributors in four additional countries.

Medigray firmographics

Firmographics
Name
Medigray
Legal name
Inversiones Oridama S.A.
Website
https://medigray.com
Company type
Private
Founded year
1988
Operating status
Operating
Headcount range
51–100 employees
Short description
Medigray (Inversiones Oridama S.A.) is a Costa Rican family-owned pharmaceutical manufacturer founded in 1988 that develops, produces, and commercializes more than 60 pharmaceutical, OTC, cosmetic, medical-device, and disinfectant products, supplying CCSS public healthcare, domestic pharmacy networks, and export distributors in four additional countries.
Ownership category
akta.pro rank

Medigray industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Pharmaceutical manufacturing
  • OTC medications
  • Dermatological products
  • Cosmetics production
  • Medical device disinfectants

Where Medigray is headquartered

Location

Headquarters

HQ city
Desamparados
HQ country
Costa Rica
HQ region
Latin America

Offices1 record

Markets served

Medigray business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Pharmaceutical Product Sales: Revenue generated from developing, producing, and commercializing pharmaceutical products including prescription medications, OTC products, and cosmetics through direct institutional sales (CCSS public sector) and retail pharmacy distribution.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels1 record

Medigray product offering

Product offering

Core offering

Medigray is a Costa Rican pharmaceutical manufacturer that develops, produces, and commercializes a portfolio of more than 60 differentiated medications and cosmetics across therapeutic categories including respiratory, pain, dermatology, gastrointestinal, antiparasitic, cardiometabolic, urological, vascular, and high-level disinfection. Products are sold through direct institutional sales to the CCSS public healthcare system, pharmacy retail networks in Costa Rica, and export distribution to four additional countries in Central America and the Caribbean.

Product overview

Medigray is a Costa Rican pharmaceutical company (founded 1988) that develops, produces, and commercializes pharmaceutical products and cosmetics. The product portfolio spans multiple therapeutic categories: Respiratory (Salbutín, Aquanasal, Herbatos), Pain/Anti-inflammatory (Megalivia, Golparén, Rolomed, Lidocaína Spray), Dermatological (Trofodermax, Biopantenol, Terminafín, Secaride, Fusicobiotic, Sport Ice), Gastric/Intestinal (Liviosan, Frutadex, Diabedex, Buco Vac), Urological (Urofos, Vigor, Vascumed), Antiparasitic (Piofín, Iverpiofin, Delix), Cardiometabolic (Diabecontrol, Ydrat), Multivitamins (IV Infusion), and High-Level Disinfectants (Ortoftaldehído, Glutaraldehído, Reactive Strips). The company also offers OTC products (Spin Deodorant, Otocerum, Lubrisex, Durasex, Aftotex, Alergel). Medigray exports to multiple countries including Dominican Republic, Panama, Peru, and El Salvador.

Differentiator

Problem solved

Functional benefit

Companies that use Medigray

Customer profile

Segments3 records

Ideal customer profiles3 records

Medigray technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Medigray partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves9 records

Expansion highlights4 records

Medigray competitors and assessment

Company assessment

Direct peers

  • Eurofarma Laboratórios: Brazilian pharmaceutical manufacturer with operations across Latin America. Comparable as a Latin American pharma manufacturer with a diversified therapeutic portfolio and regional expansion strategy.
  • Procaps S.A. Colombian pharmaceutical manufacturer with international presence across the Americas. Comparable as a regional branded pharma manufacturer with multi-country distribution and similar therapeutic-category breadth.
  • Laboratorios Asofarma: Mexican pharmaceutical company focused on specialty pharma across Latin America. Comparable as a regional branded pharmaceutical manufacturer with presence in Central American and Latin American markets.
  • Genomma Lab Internacional: Mexican pharmaceutical and personal care company focused on branded OTC products across Latin America. Highly comparable business model of developing and commercializing branded pharmaceutical and OTC products for Latin American markets.
  • Laboratorios Roemmers: Argentine pharmaceutical manufacturer with regional presence across Latin America. Comparable as a regional pharmaceutical manufacturer with diversified product portfolio and multi-country footprint.

Broad incumbents

  • Sanofi: Global pharmaceutical company with established Latin American operations. Operates broadly in the same therapeutic categories as Medigray but at much larger scale with deeper R&D and regulatory resources.
  • Pfizer: Global pharmaceutical incumbent with established presence across Latin America. Overlaps in anti-infectives, cardiometabolic, and dermatology but at much larger scale and with proprietary IP.
  • Bayer: Global pharmaceutical and life sciences company with extensive Latin American presence. Overlaps in OTC, cardiometabolic, and dermatology but as part of a much broader global portfolio.
  • Teva Pharmaceutical Industries: Global generic and specialty pharmaceutical company. Operates in the same branded-generic space as Medigray but at vastly greater scale with a global manufacturing footprint.

Regional players

  • Farmindustria S.A. Peruvian pharmaceutical manufacturer with regional presence. Comparable because Medigray already exports to Peru and operates in similar therapeutic categories; serves as a regional reference for Andean market dynamics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Medigray financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medigray leadership team

Management profile

Number of profiles

Profiles2 records

Medigray funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medigray M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medigray

What does Medigray do?

Medigray is a Costa Rican pharmaceutical manufacturer that develops, produces, and commercializes a portfolio of more than 60 differentiated medications and cosmetics across therapeutic categories including respiratory, pain, dermatology, gastrointestinal, antiparasitic, cardiometabolic, urological, vascular, and high-level disinfection. Products are sold through direct institutional sales to the CCSS public healthcare system, pharmacy retail networks in Costa Rica, and export distribution to four additional countries in Central America and the Caribbean.

Is Medigray a public or private company?

Medigray is a private company. It is classified as family owned and is currently operating.

When was Medigray founded?

Medigray was founded in 1988. It employs 51 to 100 people.

Where is Medigray based?

Medigray is headquartered in Desamparados, Costa Rica, in the Latin America region.

How does Medigray make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are Medigray's main competitors?

Direct peers on record are Eurofarma Laboratórios, Procaps S.A., Laboratorios Asofarma, Genomma Lab Internacional and Laboratorios Roemmers. Broad incumbents are Sanofi, Pfizer, Bayer and Teva Pharmaceutical Industries. Farmindustria S.A. is listed as a regional player.

Does Medigray have an API?

No public API is recorded for Medigray.

What industry is Medigray in?

Medigray's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales